11-123608773-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001387025.1(GRAMD1B):c.1628G>A(p.Arg543Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000342 in 1,551,230 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000085 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000029 ( 0 hom. )
Consequence
GRAMD1B
NM_001387025.1 missense
NM_001387025.1 missense
Scores
1
2
15
Clinical Significance
Conservation
PhyloP100: 5.54
Genes affected
GRAMD1B (HGNC:29214): (GRAM domain containing 1B) Predicted to enable cholesterol binding activity; cholesterol transfer activity; and phospholipid binding activity. Predicted to be involved in cellular response to cholesterol and cholesterol homeostasis. Located in endoplasmic reticulum membrane; endoplasmic reticulum-plasma membrane contact site; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.109454244).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRAMD1B | NM_001387025.1 | c.1628G>A | p.Arg543Gln | missense_variant | 12/20 | ENST00000635736.2 | NP_001373954.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRAMD1B | ENST00000635736.2 | c.1628G>A | p.Arg543Gln | missense_variant | 12/20 | 5 | NM_001387025.1 | ENSP00000490062.1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152148Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
13
AN:
152148
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000375 AC: 6AN: 159866Hom.: 0 AF XY: 0.0000239 AC XY: 2AN XY: 83614
GnomAD3 exomes
AF:
AC:
6
AN:
159866
Hom.:
AF XY:
AC XY:
2
AN XY:
83614
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000286 AC: 40AN: 1399082Hom.: 0 Cov.: 32 AF XY: 0.0000188 AC XY: 13AN XY: 690034
GnomAD4 exome
AF:
AC:
40
AN:
1399082
Hom.:
Cov.:
32
AF XY:
AC XY:
13
AN XY:
690034
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152148Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74332
GnomAD4 genome
AF:
AC:
13
AN:
152148
Hom.:
Cov.:
32
AF XY:
AC XY:
8
AN XY:
74332
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 30, 2023 | The c.1199G>A (p.R400Q) alteration is located in exon 11 (coding exon 11) of the GRAMD1B gene. This alteration results from a G to A substitution at nucleotide position 1199, causing the arginine (R) at amino acid position 400 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Benign
DEOGEN2
Benign
T;T;T;.;T;T;.;.;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D;D;D;D;D;D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
PrimateAI
Uncertain
T
PROVEAN
Benign
.;.;.;N;N;N;N;N;.;N
REVEL
Benign
Sift
Benign
.;.;.;T;T;T;T;T;.;T
Sift4G
Benign
.;.;.;T;T;T;T;T;.;T
Polyphen
0.071, 1.0
.;.;.;.;.;B;.;.;.;D
Vest4
0.18, 0.18, 0.16, 0.16, 0.093
MutPred
0.34
.;.;.;Gain of disorder (P = 0.1564);.;.;.;.;.;.;
MVP
0.19
MPC
0.56
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at